Advertisement

HONG KONG, Nov. 28, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO ) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2012 ended September 30, 2011.

Second Quarter of Fiscal 2012 Highlights

First Half of Fiscal 2012 Highlights

'/>"/>

SOURCE

Advertisement
Advertisement